BenchX: Benchmarking AI Models for Cancer Detection and Localization with Demographic and Protocol Biases

LLM PTSAD AI Safety / AI Ethics AFBD CV LDCAD
2026年06月23日
人工智能(AI)在医学影像领域已取得显著成就,但业界普遍认识到,这类模型在真实世界临床环境中的表现往往缺乏一致性。这种不一致性通常出现在患者人口学特征(如年龄、性别、种族)及影像采集协议存在差异的情况下,例如在检测微小肿瘤、分析不同对比剂增强时相的扫描图像,或评估不同年龄、性别的患者时。为量化此类不一致性,我们构建了一个大规模、开放的基准数据集,共包含85,355例CT扫描影像,系统性地评估了12种肿瘤检测AI模型在肿瘤大小、解剖位置、患者亚组及影像采集协议等多个维度上的性能表现。我们利用大语言模型(LLM)从临床数据中自动提取并结构化整理亚组信息,从而确保该分析兼具可扩展性与可复现性。本基准测试结果表明:当前最先进的AI模型——尽管在整体平均准确率上经过充分优化——在罕见或代表性不足的亚组(如年轻女性非洲裔美国人)中表现明显欠佳。然而,针对这些罕见病例收集足够数量且经专业标注的数据,在实践中往往难以实现。该基准数据集为构建更可靠、更具鲁棒性的肿瘤检测AI模型奠定了基础,同时也凸显出在医学影像及计算机视觉领域开展严格、细粒度亚组层面评估的必要性。相关数据集与代码均已开源。
Artificial intelligence (AI) has achieved remarkable success in medical imaging, but it is widely recognized that these models often perform inconsistently across real-world clinical settings. Such inconsistencies occur when patient demographics and imaging protocols vary, for example, in detecting small tumors, analyzing scans from different contrast phases, or evaluating patients of different ages or sexes. To quantify these inconsistencies, we develop a large-scale, open benchmark of 85,355 CT scans that systematically evaluates 12 tumor-detection AI models across tumor size, location, patient subgroup, and imaging protocol. We leverage large language models (LLMs) to extract and organize subgroup information from clinical data, which makes the analysis both scalable and reproducible. Our benchmark reveals that current state-of-the-art AI models, optimized for average accuracy, perform poorly in rare or underrepresented subgroups, such as young, female African Americans. However, collecting sufficient annotated data for these rare cases is often impractical. The benchmark provides a foundation for building more reliable and robust AI models for tumor detection and highlighting the need for rigorous, subgroup-level evaluation in medical imaging and computer vision. Datasets, code
许愿